Sunday, December 07, 2025 | 10:30 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Vivimed Labs receives approval for 3 products from its Hyderabad site

Image

Capital Market
Vivimed Labs announced today that it received approvals for 3 products from its state of the art manufacturing site in Hyderabad, which is PICS & Health Canada approved site.

1. Bilastine tablets 20mg under brand name FLUSTIN
2. Ornidazole and Otloxacin tablets under brand name ORZOLE COMBI
3. Paracetamol 12Smg/Sml and Chlorpheniramine Maleate Syrup 2mg/Sml 100mi under brand name FEBRIL

Powered by Capital Market - Live News

 

Disclaimer: No Business Standard Journalist was involved in creation of this content

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Apr 16 2021 | 2:40 PM IST

Explore News